By: Colin Jacobsen, VP Product Management - Advertising
As traditional claims struggle to keep pace, upstream signals are helping to close the gap between market activity and media activation.
Healthcare marketers have spent the past decade refining precision, improving measurement and building more sophisticated ways to reach providers and patients. Yet one of the industry's most persistent challenges has remained largely unchanged: timing.
While audience targeting has become more advanced, much of the data informing those decisions still arrives too late to influence the moments that matter most. In an industry where treatment decisions can evolve quickly, delayed visibility into patient and provider activity can limit the effectiveness of even the most well-planned campaigns.
For many pharmaceutical brands, claims data has become the standard for understanding market activity. It has helped commercial teams identify prescribing trends and healthcare utilization, measure campaign impact and build audience segments based on real-world behavior.
However, claims data is inherently retrospective. By the time a claim is generated, processed and made available for analysis, the patient has often already moved through a critical stage of care. The provider visit has happened, the prescription decision may have been made and the opportunity to shape that journey may have already passed. As expectations for performance continue to rise, relying solely on historical data has become increasingly difficult to justify.
That lag creates a disconnect between how healthcare actually happens and how healthcare marketing responds. Brand teams are being asked to make faster decisions in an environment where audience data can still reflect what happened weeks earlier.
Agencies are under pressure to improve efficiency while working with targeting inputs that can become stale before a campaign fully launches. Commercial organizations are trying to better align media investments with business outcomes, yet they often lack a signal that captures patient movement in a more immediate way. The result is a market that has become more accountable, but not necessarily more responsive.
The hurdle may not be finding more data, but finding earlier, and even predictive, data.
One emerging opportunity comes from a source that has historically existed outside of media strategy altogether: healthcare eligibility verification. Before a patient arrives for an appointment, provider offices routinely confirm insurance coverage with payers. This transaction is the request submitted by the provider to verify eligibility, including the payer's response confirming coverage details such as benefits, copays and deductibles.
Although these transactions have traditionally served an administrative purpose, they also reveal something marketers have long struggled to identify compliantly: a near real-time signal that a provider is about to have a patient encounter. That earlier visibility has the potential to change how healthcare marketing operates. Rather than waiting for downstream claims to confirm that a visit has already occurred, marketers can begin identifying relevant activity before the appointment itself. This creates an opportunity to build more dynamic audience strategies that reflect current patient and provider flow instead of relying entirely on past utilization patterns.
For pharmaceutical marketers, that means media can become better aligned with live market conditions. For agencies, it opens the door to more efficient targeting and less wasted spend. For commercial teams, it introduces a new way to understand where demand is building before it becomes visible in traditional datasets.
PurpleLab's latest innovation, Eligibility Alerts, was built to solve this challenge by giving pharma marketers four to seven days of pre-visit intelligence. It helps brands reach providers actively seeing relevant patients, improve campaign efficiency by moving beyond static historical audiences and optimize media investment using earlier market signals. By surfacing these engagement opportunities before appointments, teams can activate media and messaging when it is most relevant.
As healthcare marketing continues to evolve, competitive advantage will increasingly depend on how quickly organizations can respond to change. The companies that lead the next phase of the industry may not simply be the ones with more data, but the ones with data that enables connection at the most opportune moments, driving conversions and better health outcomes.
